Reported Saturday, BioMarin Presented New Data On VOXZOGO for Multiple Growth-Related Conditions in Children Presented At Pediatric Endocrine Society (PES) Annual Meeting
Reported Saturday, BioMarin Presented New Data On VOXZOGO for Multiple Growth-Related Conditions in Children Presented At Pediatric Endocrine Society (PES) Annual Meeting
週六報道，BioMarin在兒科內分泌學會（PES）年會上公佈了有關VOXZOGO兒童多種生長相關疾病的新數據
- Investigator-Sponsored Phase 2 Study Demonstrated Positive Results in Children with Noonan Syndrome, Idiopathic Short Stature and Other Growth-Related Conditions
- BioMarin-Sponsored Phase 3 Data Show Notable Mean Annualized Growth Velocity Increases in Children with Achondroplasia Who Started Treatment During Adolescence
- 研究人員贊助的2期研究顯示，在患有努南綜合症、特發性矮小和其他與生長相關的疾病的兒童中取得了積極結果
- Biomarin贊助的3期數據顯示，在青春期開始治療的軟骨發育不全患兒的年平均生長速度顯著增加
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。